Key result
hsCRP measurement sparks ongoing debate regarding its clinical utility versus redundancy in comprehensive risk profiling.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
James McCormack and Michael Allan discuss issues and questions surrounding hsCRP measurements in patients.
No takes yet. Share an insight, caveat, or question.
McCormack et al. (2010) studied this question. High-sensitivity C-reactive protein (hsCRP) measurement in patients is associated with ongoing debate regarding its clinical utility versus redundancy in comprehensive risk profiling.
Synapse has enriched 10 related papers. Consider them for comparative context: